News Releases

Albert Einstein College of Medicine Receives $16 Million NIH Grant to Study Cellular Process Linked to Alzheimer’s Disease
Einstein Welcomes New Class of Medical Students and Introduces Innovative Curriculum Changes
Random Gene Expression is Critical for Stem Cell Function

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Robert W. Marion

Robert W. Marion, M.D.

Area(s) of expertise: Genetic diseasesAutismSudden infant death syndrome (SIDS) and Cardiogenetics

Dr. Marion is an internationally recognized pediatric geneticist who specializes in diagnosing and treating children with autism spectrum disorders and genetic diseases. His work with the Aguirre brothers, twins who were joined at the head… Learn more

Einstein in the News


The New Yorker
It Will Take More Than a Vaccine to Beat COVID-19

Liise-anne Pirofski, M.D., discusses the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.

Additional Coverage includes Los Angeles Times, The Lancet, CNN, USA Today, Nature, The Atlantic, Wall Street Journal (subscription required ), Associated Press, NPR, LA Times, NBC News, CBS News

More coverage on this storyMore coverage on Dr. Pirofski

NIH Diabetes Discoveries & Practice Blog
Fasting Safely with Diabetes

Martin Grajower, M.D., offers tips to people with diabetes to help them avoid health problems while fasting. Dr. Grajower is clinical professor of medicine at Einstein and an endocrinologist and internal medicine physician at Montefiore.

Science News
A Man in Hong Kong is the First Confirmed Case of Coronavirus Reinfection

Kartik Chandran, Ph.D., discusses the case of a man who was reinfected with COVID-19 after he recovered from an initial bout of the disease. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.

More coverage on Dr. Chandran

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog